5.26
1.16%
0.0601
Precedente Chiudi:
$5.1999
Aprire:
$5.48
Volume 24 ore:
9,485
Relative Volume:
0.53
Capitalizzazione di mercato:
$199.29M
Reddito:
$7.80M
Utile/perdita netta:
$-69.02M
Rapporto P/E:
-2.6081
EPS:
-2.0168
Flusso di cassa netto:
$-66.61M
1 W Prestazione:
+0.19%
1M Prestazione:
-22.42%
6M Prestazione:
+46.93%
1 anno Prestazione:
+21.20%
Molecular Partners Ag Adr Stock (MOLN) Company Profile
Nome
Molecular Partners Ag Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MOLN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
MOLN | 5.34 | 199.29M | 7.80M | -69.02M | -66.61M | -2.0168 |
VRTX | 450.30 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.27 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 591.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.34 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-08-30 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-08-29 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2022-05-25 | Aggiornamento | Credit Suisse | Underperform → Neutral |
2022-04-27 | Downgrade | Credit Suisse | Neutral → Underperform |
2021-07-13 | Iniziato | Cowen | Outperform |
2021-07-12 | Ripresa | SVB Leerink | Outperform |
Mostra tutto
Molecular Partners Ag Adr Borsa (MOLN) Ultime notizie
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks
Molecular Partners shares gain on Leerink's outperform rating - Investing.com
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move ... - Yahoo News UK
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit - GlobeNewswire Inc.
Molecular Partners' New Therapy Shows AML Treatment PromiseTipRanks.com - TipRanks
Molecular Partners Unveils Promising Cancer Therapy - TipRanks
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket By Benzinga - Investing.com UK
Molecular Partners Shares Rise on Positive Trial Data for MP0317 - MarketWatch
Rigel Pharmaceuticals names new Chief Medical Officer By Investing.com - Investing.com
Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com UK
US stock market gainers for the last week of April 2022 - Nairametrics
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com India
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOsiShares Biote - Benzinga
Molecular Partners (MLLCF) Stock Price, News & Analysis - MarketBeat
Market Data Center - Barron's
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Molecular Partners Ag Adr Azioni (MOLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):